Below are Gilead’s Research Scholar Program Solid Tumor Awardees and their research titles. As the program values diverse voices and innovative research topics to address areas of unmet medical need, you do not need to duplicate previous research topics in order to be successful for an Award.
Any pre-clinical or clinical research research proposal that addresses an area of unmet medical need in Solid Tumors is welcome.
2023 Award Recipients
Elie Rassy, MD, MSc, MPH
Gustave Roussy
Villejuif, France
"A cOmprehensive study to understand the canceR Immunity cyclE iN occulT brEast canceR"
Gillian Vandekerkove, PhD
University of British Columbia
Vancouver, Canada
"Circulating tumor DNA for the prediction of prognosis and treatment resistance in metastatic urothelial carcinoma"
Céline Blaye, MD, PhD
Institut Bergonié
Bordeaux, France
| "Impact of tumor-promoting immunosuppressive myeloid cells on the acquisition of a stemness phenotype by breast cancer cells" |
Carmine DeAngelis, MD, PhD
University of Naples Federico II
Naples, Italy
"Elucidating the role of the interferon signaling pathway as a mediator of resistance to CDK4/6 inhibitors in ER-positive breast cancer"
2022 Award Recipients
Matteo Lambertini, MD, PhD
IRCCS Ospedale Policlinico San Martino - University of Genova
Genova, Italy
"Addressing reproductive issues in young women with breast cancer in the current era of personalized medicine and effective targeted therapies"
Xiaozheng Liu, PhD
VIB-KU Leuven
Leuven, Belgium
"Metabolic Evolution of Breast Cancer Metastasis Predicts Metastasis Risk at Early Stage"
Sebastian Vosberg, PhD
Medical University of Graz
Graz, Austria
"In silico characterization of the tumor immune microenvironment in luminal breast cancer"
October 2023, IHQ-UNB-4889